Exchanges

11:24 AM
Steve Grob
Steve Grob
Commentary
50%
50%

NYSE/DB: Why Brussels Got It Wrong

Not much surprise at last week's NYSE/DB news then, but the rationale for blocking the deal seems odd.

Firstly, and whatever they may claim, Brussels did take an overly Eurocentric view. Just call the CME in Chicago and ask where Liffe and Eurex appear on its list of major competitors. Secondly, the Commission claims that LIFFE and EUREX themselves compete but, in fact, they are effectively two 'mini-monopolies' operating at opposite ends of the yield curve with almost zero overlap in their products.

It's not as if the competitive landscape for European derivatives was particularly vibrant anyway. But the biggest issue concerns how the Commission calculated the potential market share for the combined entity. How could they exclude OTC derivatives in their sums when just along the corridor they are also introducing regulation aimed at pushing the OTC and exchange-traded worlds together?

That is not to say that the decision was necessarily wrong, but the reasoning behind it doesn't seem to stack up. As one of our previous polls showed, the market was pretty evenly divided on the issue but with a significant number of "don't knows".

For these swing voters, maybe it's all about capital efficiency. Ever since the financial crisis, capital has become an increasingly valuable commodity as market regulators around the world are steadily upping the requirements. Would a combined entity have been able to offer more efficient use of capital through margin offsets or otherwise netting positions for traders? Or, would a combined entity have been able to drive up prices and exploit its position without exchanges like the CME or NASDAQ jumping in?

Personally, I think Brussels might end up adding this decision to the "Not sure we got it right" pile.

Steve Grob blogs for Fidessa on various capital markets and risk matters.

Comment  | 
Print  | 
More Insights
More Commentary
Data Integrity: A Necessity, Not an Option
Financial institutions that have taken on the data integrity task in the past now have to spend more money on hardware, software, and people just to keep up with the demand.
What Colombia’s New IT Campaign Means for Latin American Tech Investment
Colombia’s campaign is the latest example of how Latin America is trying to edge into the global technology space.
Initial Margin: When Does More Turn Out to Be Less?
Changing margin regulations are set to affect the OTC derivative market, including initial margin risk models for non-cleared OTCs.
The Mainframe Innovation Drag
It may be time for a consortium of firms motivated around the objective of eliminating the mainframe. What if every self-clearing firm decided to participate in building a modern, back-office system as an open-source, cloud-based project?
Big Data DIY
Now that we have passed the initial hype phase of big data, companies are searching for real business value from their investments. Consultants can play a part, but only if financial firms insist on a new partnership model.
Register for Wall Street & Technology Newsletters
White Papers
Current Issue
Wall Street & Technology - July 2014
In addition to regular audits, the SEC will start to scrutinize the cyber-security preparedness of market participants.
Video
Exclusive: Inside the GETCO Execution Services Trading Floor
Exclusive: Inside the GETCO Execution Services Trading Floor
Advanced Trading takes you on an exclusive tour of the New York trading floor of GETCO Execution Services, the solutions arm of GETCO.